Menu
Montecito
American Riviera
Loading...
You are here:  Home  >  'oncology'  -  Page 2
Latest

New drugs boost profits at Amgen as two executives leave company

By   /  Friday, August 3rd, 2018  /  Central Coast Health Watch, Earnings, East Ventura County, left, Tri-County Public Companies  /  Comments Off on New drugs boost profits at Amgen as two executives leave company

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen makes second investment in Sutro Biopharma

By   /  Monday, July 30th, 2018  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen makes second investment in Sutro Biopharma

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen drugs Kyprolis and Prolia gain approvals

By   /  Monday, June 11th, 2018  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen drugs Kyprolis and Prolia gain approvals

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen joins research and education partnerships

By   /  Thursday, May 31st, 2018  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen joins research and education partnerships

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets FDA approval to change Kyprolis label

By   /  Thursday, January 18th, 2018  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen gets FDA approval to change Kyprolis label

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen’s Kyprolis found to increase cancer survival rate

By   /  Thursday, July 13th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen’s Kyprolis found to increase cancer survival rate

A Phase 3 clinical study of Amgen’s multiple myeloma drug Kyprolis showed that it increased overall survival rate when paired with lenalidomide and dexamethasone versus just those two drugs alone. The drug reduced the risk of death by 21 percent, and patients lived 7.9 months longer when on a regimen that included Kyprolis than those Read More →

Read More →